Skip to main content
. 2015 Sep 21;64(12):1531–1539. doi: 10.1007/s00262-015-1758-5

Table 3.

Multivariate analysis of key parameters and clinical outcomes

Parameter Hazard ratio (DFS) p value (DFS) Hazard ratio (OS) p value (OS)
Stagea 0.58b 0.21b
 III 1.3 0.32 1.4 0.3
 IV 1.3 0.35 0.87 0.75
 III versus IV 1.0 0.91 0.6 0.12
Gender 0.76 0.12 0.66 0.07
Age 1.03 0.90 1.26 0.39
Immune response 0.93 0.69 1.05 0.83

aThe reference group is patients with stage II melanoma unless otherwise stated

bCumulative p value for all stages